Mediastinal Single Nodal Relapse of a Nasal NK/T Cell Lymphoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A nasal NK/T cell lymphoma is a very aggressive form of lymphoma. Patterns of relapse after treatment have not been systematically evaluated, and mediastinal nodal relapse at a primary site has never been documented. We describe here a 40-year old man who presented with a nasal obstruction caused by a protruding mass that was identified as a nasal NK/T cell lymphoma. The initial work-up, including chest and abdominopelvic computed tomography (CT) and positron emission tomography (PET), showed no regional or distant metastasis. A CT scan performed following three cycles of chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) showed that the mass had nearly disappeared. Radiation therapy undertaken following chemotherapy was given to the primary site. However, PET performed following radiotherapy revealed a single mediastinal lymphadenopathy, with no evidence of residual tumor in the nasal cavity. A biopsy using video-assisted thoracoscopy (VATS) showed the presence of a recurrent NK/T cell lymphoma with an immunophenotype identical to that of the primary nasal lymphoma. An additional three cycles of CHOP chemotherapy were administered, and the patient remains alive, with no evidence of disease 30 months after the initial relapse. These findings indicate that early detection with PET and prompt surgical excision with the use of VATS can lead to successful treatment of a relapsed nasal NK/T cell lymphoma.
Abstract
A nasal NK/T cell lymphoma is a very aggressive form of lymphoma. Patterns of relapse after treatment have not been systematically evaluated, and mediastinal nodal relapse at a primary site has never been documented. We describe here a 40-year old man who presented with a nasal obstruction caused by a protruding mass that was identified as a nasal NK/T cell lymphoma. The initial work-up, including chest and abdominopelvic computed tomography (CT) and positron emission tomography (PET), showed no regional or distant metastasis. A CT scan performed following three cycles of chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) showed that the mass had nearly disappeared. Radiation therapy undertaken following chemotherapy was given to the primary site. However, PET performed following radiotherapy revealed a single mediastinal lymphadenopathy, with no evidence of residual tumor in the nasal cavity. A biopsy using video-assisted thoracoscopy (VATS) showed the presence of a recurrent NK/T cell lymphoma with an immunophenotype identical to that of the primary nasal lymphoma. An additional three cycles of CHOP chemotherapy were administered, and the patient remains alive, with no evidence of disease 30 months after the initial relapse. These findings indicate that early detection with PET and prompt surgical excision with the use of VATS can lead to successful treatment of a relapsed nasal NK/T cell lymphoma.
참고문헌 (20)
- Cheung MM, "Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients", 16, pp.70~77 (1998)
- Ooi GC, "Nasal T-cell", natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity, 2000, pp.174, 1141~1145
- Chan JK, "Extranodal NK", T cell lymphoma, nasal type, 2001, 204~207[DOI]
- Jaffe ES, "Report of the Workshop on Nasal and Related Extranodal Angiocentric T", Natural Killer Cell Lymphomas: definitions, differential diagnosis and epidemiology, 1996, pp.20, 103~111
- Ferry JA, "Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis", pp.268~279 (1991)
- Liang R, "Treatment outcome and prognostic factors for primary nasal lymphoma", 13, pp.666~670 (1995)
- Kim GE, "Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment", 18, pp.54~63 (2000)
- Chim CS, "Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index", 103, pp.216~221 (2004)
- Ko YH, "NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status", 44, pp.480~489 (2004)
- Yao B, "Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity: a report of 129 cases", 25, pp.465~470 (2006)
- Lee J, "Extranodal natural killer T-cell lymphoma, nasal type: a prognostic model from a retrospective multicenter study", 24, pp.612~618 (2006)
- Meneses A, "Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma", pp.69~72 (1993)
- Li YX, "Radiotherapy as primary treatment for stage IE and IIE nasal natural killer", T-cell lymphoma, 2006, pp.24, 181~189
- Kim K, "Treatment outcome of angiocentric T-cell and NK", T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy, 2005, pp.35, 1~5
- Ng WK, "Nodal presentation of nasal type NK", T-cell lymphoma: report of two cases with fine needle aspiration cytology findings, 2003, pp.47, 1063~1068
- Gutte H, "Early clinical experience and impact of 18F-FDG PET", 26, pp.989~994 (2005)
- Brix G, "A survey of PET activity in Germany during 1999", 29, pp.1091~1097 (2002)
- Radford JA, "The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease", pp.940~946 (1988)
- Surbone A, "Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy" (1832)
- Magnani B, "The real impact and usefulness of video-assisted thoracoscopic surgery in the diagnosis and therapy of clinical lymphadenopathies of the mediastinum", 10, pp.1197~1202 (2003)